Nachrichten zur Idorsia AG Aktie

GNW-Adhoc: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million

^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 20, 2023 Idorsia Ltd (SIX: IDIA)…

^Idorsia will publish its half year financial results 2023 on Tuesday July 25, 2023, at 07:00 CEST. An…

^Ad hoc announcement pursuant to Art. 53 LR * The approximately 20 million US lives…

^Allschwil, Switzerland - June 26, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia's…

^Allschwil, Switzerland - June 23, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia's…

^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - June 20, 2023 Idorsia Ltd (SIX: IDIA)…

^* QUVIVIQ(TM) wird angewendet zur Behandlung von Erwachsenen mit Schlafstörungen (Insomnie), deren Symptome…

^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - June 06, 2023 Idorsia Ltd …

^Ad hoc announcement pursuant to Art. 53 LR * Simon Jose to step down from…

^* Alle Anträge des Verwaltungsrates von den Aktionären angenommen Allschwil, Schweiz - 4. Mai 2023 An der heute…

^* QUVIVIQ is indicated for the management of adult patients with insomnia, characterized…

^Ad-hoc-Mitteilung gemäss Art. 53 KR Allschwil, Schweiz - 25. April 2023 Idorsia Ltd (SIX: IDIA) gab heute die…

^Idorsia will publish its first quarter financial results 2023 on Tuesday April 25, 2023, at 07:00 CEST. An…

^Allschwil, Schweiz - 6. April 2023 Idorsia Ltd (SIX: IDIA) veröffentlichte heute im Namen des Verwaltungsrates die Einladung…

^* Chronic insomnia disorder (CID) is a persistent medical condition that prevents sufferers…

^Ad-hoc-Mitteilung gemäss Art. 53 KR Allschwil, Schweiz- 7. Februar 2023 Idorsia Ltd (SIX: IDIA) gab heute die Finanzergebnisse…

^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - February 6, 2023 Idorsia Ltd (SIX: IDIA)…